Literature DB >> 31470859

Asbestos exposure and malignant mesothelioma of the tunica vaginalis testis: a systematic review and the experience of the Apulia (southern Italy) mesothelioma register.

Luigi Vimercati1, Domenica Cavone2, Maria Celeste Delfino2, Luigi De Maria2, Antonio Caputi2, Giovanni Maria Ferri2, Gabriella Serio3.   

Abstract

BACKGROUND: Malignant mesothelioma of the tunica vaginalis testis (MMTVT) is a rare disease with a poor prognosis. The diagnosis and management of these lesions are often difficult for pathologists, surgeons, oncologists and occupational physicians. A preoperative diagnosis of malignancy is rarely made, and there is no established effective therapy except orchidectomy.
METHODS: A systematic literature review was conducted among the articles published in the English literature on primary MMTVT. Moreover four cases from the Apulia mesothelioma register are reported here.
RESULTS: Two hundred eighty-nine cases of MMTVT have been reported from 1943 to 2018. Overall asbestos exposure has been investigated only for 58% of all cases reported in this review, while in 41.8% this data are not available. Noteworthy is the fact that in many reports there is not an anamnestic reconstruction of any asbestos exposure. A history of direct occupational, environmental or familial asbestos exposure is found in 27.6% of the cases. The four cases from the Apulia mesothelioma register are all with ascertained occupational exposure to asbestos.
CONCLUSIONS: The true incidence of asbestos exposure in MMTVT is underestimated because of insufficient information reported in older literature. To establish a broad consensus on the causal relationship between asbestos and MMTVT in the scientific community its necessary to analyze the same variables in the epidemiological studies. In general it should be recommended that a positive history of exposure to asbestos or to asbestos-containing materials are at risk for the development of a MMTVT and should be monitored.

Entities:  

Keywords:  Apulia southern Italy; Asbestos; Mesothelioma; Mesothelioma register; Review; Tunica vaginalis

Mesh:

Substances:

Year:  2019        PMID: 31470859      PMCID: PMC6717382          DOI: 10.1186/s12940-019-0512-4

Source DB:  PubMed          Journal:  Environ Health        ISSN: 1476-069X            Impact factor:   5.984


Background

Malignant mesothelioma (MM) is a rare tumour that can occur in the body cavities covered by mesothelium, i.e., the pleura, peritoneum, pericardium and testicular vaginal tunica [1], with benign and malignant variants. Among MM cases, a very small percentage (< 3%) [2] arise in the tunica vaginalis testis. Malignant mesothelioma of the testicular vaginal tunica (MMTVT) is very rare with potentially aggressive behaviour, and it can invade the testicular parenchyma, spermatic cord, epididymis and subcutaneous tissue of the penis; therefore, it has also been classified with the term paratesticular mesothelioma [3], rather than adenomatoid tumours, malignant adenomatoid tumours, mixed mesoblastic tumours or other various diagnoses, which is how it has been misinterpreted in the past [4-9]. The confusion over nomenclature was due to the difficulty of histological classification [10]. Over the years, three groups of mesothelial tumours have been identified, defined and classified: well differentiated papillary mesothelioma (WDPM); an emerging diagnostic category of papillary mesothelioma with borderline features or localized mesothelioma of low grade malignancy, also called mesothelioma of uncertain malignant potential (MUMP); and mesothelioma of low malignancy potential (MLMP) [11, 12], representing a morphological continuum between WDPM and malignant mesothelioma (MM) [11, 13]. As reported by Rankin (1956) [10] and by Kossow (1981) [14], the first two cases of mesothelioma of the genital tract were reported in 1912 by Naegeli [15] and in 1916 by Sakaguchi [16], followed by Thompson (1936), Evans (1943), Golden and Ash (1945), Lee (1950), Bailey (1955) and Barbera (1957) [4, 17–21], although the last was actually classified as benign papillary mesothelioma (WDPM). These cases were described by various names until 1970, when Marcus and Lynn [22] demonstrated by electron microscopy that there were no differences between so-called adenomatoid tumours and malignant mesothelioma [23]. To date, the WHO(world health organization) classification of tumours of the urinary system and male genital organs [24], in the classification of tumours of the testis and paratesticular tissue, has reported MM and the WDPM, noting that the latter “may have a progression to malignant mesothelioma if the lesions are not completely excised”. This review points out only case series and case reports of primary MM of the tunica vaginalis testis. We conducted a comprehensive review from Medline (National Library of Medicine database) and a PubMed database search of the English medical literature and on the references lists of published articles. Nevertheless, the data are often incomplete or not comparable due to the long period covered by the scientific literature examined (1943-2018) and the relative evolution of diagnostic techniques and classifications of mesotheliomas, as well as knowledge about the risk factors related to the onset of the disease [5, 21, 25, 26]. Similarly, despite the rarity of this disease, all of the various reviews reported might not indicate the true incidence because of the relatively recent agreement about the definition of the clinicopathologic entity. In addition, we report four cases from the Apulia (Southern Italy) mesothelioma register.

Methods

A PubMed computerized search was performed using the following keywords: mesothelioma tunica vaginalis testis (127 articles), testicular (276 articles), paratesticular (50 articles), testis (179 articles), and scrotum (46 articles); and it was filtered for human patients and English language. The English literature search without time limits, from 1943 to 2018, the cut-off date was December 15, 2018, and were identified a total of more than 276 previously published scientific articles on MMTVT (MEDLINE-PUBMED National Library of Medicine, National Center for Biotechnology Information; available from URL: http://www.ncbi.nlm.nih.gov/pubmed). We undertook a review using the following criteria: we excluded articles with the diagnosis of benign mesothelioma as stated by the authors on the basis of histopathological findings and cases of adenomatoid tumours and other benign tumours and WDPM [27], although some authors, such as Grove (1989) [28], suggested that these tumours should always be considered “borderline malignancy”. Similarly, cases with doubtful primary tumour origin or with concomitant pleural or peritoneal disease were excluded. Using the above criteria, the review of the literature to date revealed 289 previously described cases in 165 published articles from PubMed and from the reference lists of the available publications in the English literature, which we considered bona fide malignant MTVT(Table 1) [4, 5, 9, 11–14, 23, 28–184].
Table 1

Summary features MMTVT cases (1943-2018)

YearAuthor (Reference)N° CasesAge YearsAsbestos Exposure (latency in years)Follow Up MonthsSide-LateralityHistologic SubtypeRecurrence MonthsClinical Presentation Onset
11943Evans [4]266NA2LEFTNANAMASS
53NANALEFTNANASMALL NODULE PAINLESS
21945Robinson [28]230NANANANANANA
28NANANANANANA
31947Patterson [29]1NANANANANANANA
41949Foote [30]1NANAdeadNANAmetastasisNA
51949Fajers [5]527NANARIGHTNANANA
35NANALEFTNANANA
50NANALEFTNANANA
45NANARIGHTNANANA
58NANaRIGHTNANANA
61958Reynolds [31]145NO6 aliveRIGHTpapillary epithelioidNALARGE MASS HYDROCELE
71968Kozlowski [32]163NANAspermatic cordbiphasicNAMASS
81968Abell [9]278NA45 deadNAbiphasicmetastasisNA
70NA16 deadNAbiphasicmetastasisNA
91969Kasdon [33]258NA36 deadRIGHTpapillary epithelioid12HYDROCELE
72NA36 recurrenceRIGHTpapillary epithelioId5HYDROCELE
101969Arlen [34]140NA216LEFT spermatic cordNAmetastasisMASS
111973Johnson [35]123NA3RIGHTpapillary epithelioid3 aliveSWELLING AND MILD DISCOMFORT
121975Fishelovitch [36]160NA12 aliveLEFTpapillary epithelioidNOSWELLING, HYDROCELE
131976Fligiel [37]168pipe insulator for 40 years (pleural plaque)20 deadRIGHTpapillary epithelioidNAPAIN AND SWELLING
141976Pugh [38]2NANO48 aliveNApapillary epithelioidNOHYDROCELE
NANO84NApapillary epithelioid84 recurrenceHYDROCELE
151976Pizzolato [39]157Sugar raffinery worker41 deadRIGHTpapillary epithelioid12 recurrenceURETHRAL STRUCTURE, SECONDARY URINARY EXTRAVASION WITH URETHRITIS AND RECURRENT INGUINAL HERNIA
161977Eimoto [40]135NO2 deadLEFTfibrousNASWELLING
171977Tuttle [41]137NANARIGHT spermatic cordfibrousNAMASS
181978Sinha [42]165NA24 aliveRIGHTpapillary epithelioidNASWELLING
191978Jaffe [43]177NO12 deadLEFTpapillary epithelioidLocal recurrenceSWELLING
201981Benisch [44]164NO8SCROTUM NAfibrousNOMASS
211981Kossow [14]150NA24 NEDRIGHTpapillary epithelioidNOMASS
221981Blitzer [45]174NA30LEFT spermatic cordNANOPAINLESS, MASS
231982Japko [46]130Insulator for 8 years6 NEDRIGHTBiphasicNOSWELLING
241982Chen [47]164NA30 deadRIGHTBiphasic24 recurrenceSWELLING
251982Hollands [48]163NA24RIGHT TESTISBiphasic12 recurrenceHYDROCELE, SWELLING
261982Slaysman [49]120NA Maffucci SyndromeNAbilateralpapillary epithelioidRecurrence bilateralSWELLING
271983Zidar [50]163NA32NApapillary epithelioidNANA
281983Mc Donald [51]221NA24RIGHT HEMI-SCROTUM bilateralpapillary epithelioid24 recurrencePAINFUL GRADUAL ENLARGMENT
29NA20 NEDRIGHT HEMI-SCROTUMpapillary epithelioidNO 20PAINFUL GRADUAL ENLARGMENT
291983Van Der Rhee [52]186NO36 deadLEFT HEMI-SCROTUMpapillary epithelioid12 recurrenceHAEMATOSCROTUM
301984Antman [53]658pipefitter60LEFT INGUINALpapillary solid polypoid tissue60 metastasisHYDROCELE, INGUINAL HERNIA
73shipyard plumber for 25 years33 deadRIGHTpapillary epithelioid12 metastasisHYDROCELE
23NA180LEFTNA180 metastasisSLOWLY ENLARGEMENT
63machinist for 20 years48 deadLEFTpapillary epithelioid4 metastasisMASS
52NO24 deadRIGHTpapillary epithelioid14 metastasisMASS
43construction worker for 16 years48 NEDRIGHTpapillary epithelioidNOEPIDIDIMITE
311984Yamanishi [54]134NA6RIGHTbiphasicNOMASS
321984Khan [55]142NO9 deadRIGHT epididymisbiphasic6 metastasisPAINFULL, SWELLING
331985Vakalikos [56]126NA12 NEDRIGHTpapillary pseudotu-bularNO 12SWELLING INGUINAL
341985Ehya [57]163NA52LEFTpapillary epithelioid50 metastasisHYDROCELE
351986Karunaharan [58]140plastic fenolica worker for 20 years14 deadRIGHTglandular structure papillary epithelioid9 metastasis 12 local recurrenceIRREGULAR MASS
361986Petersen [59]151NA30NANA30 alive recurrenceNA
371987Cartwright [60]149NA4RIGHTpapillary epithelioid24 metastasisHYDROCELE
381987Fitzmaurice [61]172NA18 NEDLEFTpapillary epithelioidNO 18SWELLING
391988Linn [62]120NANALEFTpapillary epithelioidNAPAIN, SWELLING
401988Prescott [63]161Pleural plaques21 deadLEFT

Biphasic papillary, pseudo-glandular

component

8

Local recurrence metastasis

HYDROCELE
411988Velasco [64]114NA24LEFTpapillary epithelioidNO 24ABDOMINAL MASS
421989Tyagi [65]179Shipyard worker24 deadLEFTpapillary epithelioidmetastasisSWELLING
431989Grove [27]66Carpenter for 10 years42RIGHTpapillary epithelioid

24 metastasis

42 alive local recurrence

SWELLING

HYDROCELE

79NO60 deadRIGHTepithelial papillary60 Prostatic metastasisMASS
58NO108 NEDLEFTTubule papillary108 NEDHYDROCELE
441990Kamiya [66]132NO5LEFTpapillaryNO 5ELASTIC AND INDOLENT TUMOR
451990Smith [67]157NOaliveLEFTpapillary epithelioid48 Local recurrence metastasisSWELLING
461990Carp [23]154NO64 deadLEFTpapillary epithelioid38 Local recurrence metastasisMASS
471991Kuwabara [68]160NO65 deadRIGHTBiphasic60 metastasisSWELLING
481992Pfister [69]17NA16LEFTpapillary epithelioidNO 16SWELLING
491992Adler [70]162occupational12RIGHTNANO 12PAINFUL ENLARGEMENT
501992Serio(7 [71]169railway cleaner for 10 years10LEFTtubulo-papillaryNO 10SWELLING
511992Noble [72]162NANALEFTpapillary epithelioidNASWELLING, HYDROCELE
521992Fields [73]191Steel industry worker indirect exposureNANABiphasicNASWELLING
531994Moch [74]180NO25 NEDRIGHTpapillary epithelioidNOPAINLESS SWELLING
541994Saw [75]163Occupational for 7 years [20]6LEFTBiphasicNO 6HYDROCELE
551994Reynard [76]176NANARIGHTtubulo-glandular1 recurrencePAINLESS SWELLING
561994Wenger [77]125NANARIGHTNANAPAINFUL MASS
571994Watanabe [78]167Insulator for 17 years asbestosis10 deadLEFTbiphasicmultifocalNA
581995Amin [79]159NO189RIGHTpapillary epithelioidNO 188PAINLESS SWELLING
591995Magoha [80]1NANANANAfibrousNANA
601995

Huncharek

[81]

145insulator Electrical power plant144RIGHTepithelialNOPAINLESS MASS
611995Umekawa [82]167NO8 deadRIGHTepithelial6 metastasisSWELLING
621995Eden [83]262NO6LEFTNANO 6HYDROCELE
76Chemist for 10 years27 aliveLEFTepithelial6 recurrenceHYDROCELE
631995Joseph [84]126NANALEFTNANATWO PINK TO-PURPLE NODULES
641995Lopez [85]147NA36NApapillary epithelioidNO 36HYDROCELE
651995Jones [86]1175NALost follow upNAepithelialNAHYDROCELE
12NA12 nedNAepithelialNO 12HYDROCELE
39NO3NAepithelialNAPARATESTICULAR MASS
50NO24NAepithelial24 local recurrenceHYDROCELE
41NO3NAbiphasicNAPARATESTICULAR MASS
65NA180NAbiphasic180 metastasisPARATESTICULAR MASS
76pipe fitter for 10 years48 deadNAbiphasicNAHYDROCELE
58NA36 deadNAbiphasicNAHYDROCELE
67NO3NAbiphasicNAPARATESTICULAR MASS
70NA48 deadNAepithelialNAHYDROCELE
42NA24NAepithelialAlive with diseaseHYDROCELE
661996Ahmed [87]180dock worker for 10 years24 deadLEFTpapillary epithelioid3 local recurrenceHYDROCELE
671996Ascoli [88]155Insulator6RIGHTbiphasicNASWELLING
681996Mathew [89]270NA3 deadLEFTNAspinal metastasisSWELLING
58NA2 deadRIGHTNAspinal metastasisENLARGMENT
691997Berti [90]175NO15LEFTpapillary epithelioidNO 15HYDROCELE
701997Agapitos [91]260NA20LEFTbiphasicNASWELLING
84NA10LEFTbiphasicNO 10HYDROCELE
711997Khan [92]16NA24BILATERALpapillary epithelioidNO 24HYDROCELE
721998Gupta SC [93]136NO10RIGHTpapillary epithelioid1,5 metastasisHYDROCELE
731998Lee [94]245NA4RIGHTNA4 metastasisHYDROCELE
66NA6LEFTpapillary epithelioidNO 6HYDROCELE
741998Plas [95]114NO12RIGHTpapillary epithelioidNO 12ENLARGEMENT
751999Kanazawa [96]138maintenance air conditioning system for 20 years156BILATERALepithelial36 local recurrenceINGUINAL HERNIA
761999Harmse [97]170NO120RIGHTepithelialNAMASS
771999Gupta NP [98]269NA18 deadRIGHTbiphasicmetastasisSWELLING
51NA5 deadLEFTbiphasicmetastasisENLARGEMENT
782000Fujisaki [99]132NO36RIGHTepithelialNO 36SWELLING
792000Poggi [100]147NA8RIGHTepithelialNAPARATESTICULAR MASS
802000Attanoos [13]371dockyard crane driver for 20 years (ASBESTOS BODIES)NARIGHTbiphasicNAHYDROCELE
77NO50LEFTepithelialNAMASS
33NO37LEFTepithelialNAMASS
812000Ferri [101]164NA36NAepithelialNAOSTRUZIONE CERVICO-URETRALE
822001

Wolanske

[102]

171NO3RIGHTNANO 3NODLE
832001Sebbag [103]234NO62 aliveLEFTepithelialNO 6OINGUINAL MASS
19NO24 deadLEFTepithelial11 recurrenceSCROTAL MASS
842001Gurdal [104]167NO30RIGHTepithelial24 recurrenceHYDROCELE RECIDIVANTE
852002Abe [105]181NO12 deadLEFTepithelial7 metastasisHYDROCELE
862002Bruno [106]185NONARIGHT HEMI-SCROTUMepithelialNASWELLING
872002

Iczkowski

[107]

171NO26 deadLEFT HEMI-SCROTUMepithelial19 liver metastasisPAINFULL SWELLING
882003Black [108]167NA36 deadRIGHTepithelial3 recurrenceHYDROCELE
892003Garcia de Jalon [109]178carpenter3RIGHTtubulo-papillary3 metastasisINCREASE IN THE VOLUME THE TESTIS
902004Pelzer [110]121NO24BILATERALepithelialNARECURRENT PAIN
912004Sawada [111]148NO72RIGHTbiphasicNO 72SWELLING
922004Mishra [112]175NANANANANANA
932004Shimada [113]164NO18RIGHTbiphasic80% sarco-matoidNOSWELLING
942005Wang [114]181NONARIGHTtubulo-papillaryNASCROTAL MASS
952005Gorini [115]267maintenance of locomotives for 30 years [42]24LEFTepithelialNO 24MASS
80maintenance of tractors for 6 years [67]24RIGHTbiphasicNASWELLING
962005Spiess [116] (no individual data)557-8345-68 (4 dead 1 disease free survival 68)NANAMetastasis in 4 casesNA
972006

Van Apeldoorn

[117]

183NO but with pleural thickening at CT1 deadRIGHTepithelialliver metastasis

SCROTAL ENLARGEMENT

Chyluria

982006Schure [118]345NO48LEFTNANO 48SWELLING
35NO4 deadLEFTNA2 metastasisMASS INGUINO-SCROTAL
26NO18LEFTNANO 18INGUINAL MASS
992006

Winstanley

[119]

1854NO12 deadRIGHTNANAFOLLOWING A FALL
56Dockyard worker60NANA60 metastasisSOVRAPUBIC MASS
59NO24 deadLEFTNANARECURRENT HYDROCELE
52NO48LEFTNANO 48RECURRENT HYDROCELE
49NA24NANANO 24HYDROCELE
79NA1LEFTNANO 1HYDROCELE
70NA12 deadRIGHTNANABLOOD STAINED HYDROCELE
62NA24 deadLEFTNANORECURRENT HYDROCELE
45NA6LEFTNANO 6SWELLING TESTICULAR
65NA60RIGHTNANO 60HYDROCELE
75NO36LEFTNANAHYDROCELE
73NO12 deadLEFTNA12 metastasisTESTICULAR SWELLING
45NA72NANANO 72NA
58NO36LEFTNANO 36HYDROCELE HISTORY E YEARS
NANANANANANANA
NANANANANANANA
NANANANANANANA
NANONANANANANA
1002007Al Qahtani [120]139NA84LEFTNANO 84HYDROCELE
1012007Liguori [121]168NA70LEFTepithelial24 recurrenceINGUINAL MASS
1022007Guney [122]145NO3RIGHTpapillaryNO 3TESTICULAR MASS
1032008Boyum [123]160NO23LEFTbiphasicNA

SCROTAL SWELLING

RECURRENT EPIDIDYMITIS

1042008Candura [124]138petrochemical worker for 16 years15RIGHTepithelialNO 15HYDROCELE
1052008Mathur [125]265FarmerNALEFTpapillaryNASWELLING
60NANARIGHTepithelialNASWELLING
1062008Ikegami [126]167Painting worker26 deadRIGHTepithelial24 liver metastasisPAINLESS SWELLING
1072008Barui [127]142NONARIGHTtubulo-papillaryNASCROTAL MASS
1082008Goel [128]165Farmer72LEFTepithelialNAPAINLESS SWELLING
1092009Al Salam [129]183NONALEFTepithelialNASCROTAL SWELLING
1102009Baccheta [130]163NO30 deadRIGHTepithelialNANA
1112009Chen [131]167Occupational [40]7RIGHTbiphasicNO 7RIGHT HYDROCELE AND LONG-STANDING BILATERAL HYDROCELE
1122009De Lima [132]115NO12RIGHTepithelialPAINLESS INCREASE IN SCROTUM VOLUME
1132010

Brimo MUMP

[11]

843NA108 aliveNA

papillary

tubulo

papillary

108 NEDHYDROCELE
49NA24 aliveNA

papillary

tubulo

papillary

24 NEDHYDROCELE
73NA8 aliveNA

papillary

tubulo

papillary

8 NEDHYDROCELE
34NA36 aliveNA

papillary

tubulo

papillary

36 NEDSCROTAL MASS
61NA60 deadNA

papillary

tubulo

papillary

18 NEDHYDROCELE
53NA564 deadNA

papillary

tubulo

papillary

564HYDROCELE
57NANANA

papillary

tubulo

papillary

NAHYDROCELE
50NANANA

papillary

tubulo

papillary

NAHYDROCELE
1142010

Aggarwal

[133]

175NA76 deadLEFTNA30 recurrenceSCROTAL ENLARGEMENT
1152010Bisceglia [134]174NO101RIGHTtubulo-papillary24 recurrenceTESTICULAR PAIN
1162010Klaassen [135]137NO6LEFTpapillary epitheliode6 NOMASS
1172011Trpkov [12]MUMP157NO72 NEDNApapillary epitheliodeNOHYDROCELE
1182011Gupta R [136]180NANARIGHT

tubulo-

papillary

NASWELLING OF 3 YEARS DURATION
1192011Park [137]165Foundry worker for 4 years6 deadLEFTpapillary3 recurrencePALPABLE MASS
1202011Grey Venyo [138]169NONALEFTepithelial2 recurrenceSWELLING
1212011Bass [139]164worked on a naval vessel44 aliveLEFTpapillary20 recurrenceSCROTAL SWELLING
1222012Ahmed [140]178NO6RIGHTepithelioidNO 6PAINFUL SWELLING
1232012Whan Doo [141]136NO1RIGHTNANO 1PAINLESS SWELLING
1242012

Abdelrahman

[142]

154FarmerNARIGHTbiphasicNASWELLING
1252012Esen [143]138NO26LEFTepitheloidNO 26PAIN AND SWELLING
1262012Bo Hai [144]626NO24LEFT spermatic cordepithelialNO 24SPERMATIC CORD MASS
67NO24LEFTepithelialLocal recurrenceSCROTAL MASS, BILATERAL HYDROCELE
57NO24

RIGHT

spermatic

cord

epithelialLocal recurrenceMASS
46YES24 deadLEFTepithelialDODACUTE APPENDIX, TESTIS PAIN
78NO24LEFTepithelialLocal recurrenceSCROTAL MASS, BILATERAL HYDROCELE
76YES24 deadLEFTepithelialDODSCROTAL MASS
1272012Priester [145]171NA24 deadRIGHTepithelial17 recurrenceHYDROCELE
1282012Heng Yen [146]153NO36LEFTtubulopapillaryNO 36RECURRENT EPIDIDYMITIS, HYDROCELE
1292012Mrinakova [147]120environmental41LEFT TESTISpapillaryNO 41PAINLESS HYDROCELE
1302012Mensi [148]1372NA8RIGHTepithelialNAHYDROCELE AND ENLARGEMENT
73Familial for 4 years44LEFTbiphasicNAHYDROCELE
76Occupational maintenace worker for 32 years9LEFTepithelialNASCROTAL HERNIA
80Household for 11 years18RIGHTbiphasicNAHYDROCELE
60NA15RIGHTepithelialNAINGUINAL-SCROTAL HERNIA
82Occupational spinner for 32 years25LEFTsarcomatousNATESTICULAR MASS
38Occupational maintenace worker for 16 years33RIGHTepithelialNATESTICULAR PAIN AND SPERMATIC CORD TORSION
69NA52LEFTdesmoplasticNAHYDROCELE
85NA14LEFTpoorly differentationNAHYDROCELE
69NA39LEFTsarcomatousNATESTICULAR MASS
76Occupatonal textile worker for 11 years42RIGHTepithelialNAHYDROCELE
77Occupational bricklayer for 24 years8LEFTepithelialNAHYDROCELE
74Occupatonal bricklayer for 28 years6LEFTepithelialNATESTICULAR MASS, HYDROCELE
1312012Vijayan [149]189Familial (son asbestosis)3 deadLEFTpapillary1 recurrenceSWELLING
1322012Shelton [150]1NANANANAtubulo papillaryNANA
1332012Gemba no individual data [151]5na3 /5 (construction, shipbuilding, steel production)NANANANANA
1342013

Busto Martin

[152]

161NO120RIGHTbiphasicNO 120INCREASE OF RIGHT SCROTUM SIZE WITH PAIN
1352013Gkentzis [153]155NANALEFTepitheliod24 recurrenceMASS PALPABLE
1362013Weng [154]128NO12LEFT

tubulo

papillary

NO 12SCROTAL TENDERNESS AND SWELLING
1372013Meng [155]145NO6 alive NEDLEFTepitheliodNOMASS
1382013Rajan [156]118NA14 deadLEFTpapillary,multycistic10 metastasisSCROTAL PAIN AND SWELLLING
1392013MeisenKothen [157]960Occupational asbestos cement pipe and domestic for 10 years [53]15 deadRIGHTNA15 recurrenceNA
70Familial domestic occupational mechanic for 30 years [64]46 aliveRIGHTepithelioidNO 46NA
59Domestic occupational US navy railroad [48]71 aliveRIGHTepithelioidNO 71MASS
44Occupational mining worker for 24 years [26]14 dead

RIGHT

Spermatic cord

epithelioid14 DODNA
74occupational shipping industry for 30 years [58]54 deadRIGHTbiphasic24 recurrenceINGUINAL MASS
63Occupational automobile manufacturing for 8 years [48]1 deadRIGHTephitelioid1 metastasisNA
51Hobby and occupational asbestos cement pipe for 7 years [41]54 aliveLEFTepithelioidNO 54HYDROCELE
51Occupational petrochemical plant worker and hobby for [31]43 aliveRIGHTNANO 43NA
65Occupational mechanic and hobby for 23 years [49]39LEFTepithelioidNO 39NA
1402014Lin Nei Hsu [158]17650 years house environmental residential8RIGHTbiphasicNOSWELLING
1412014Gomes da Fonseca [159]162NO5 deadLEFTepithelioid3 metastasisENLARGEMENT
1422014Stradella [160]151Possible occupationalNARIGHTbiphasicNAHYDROCELE
1432014Yang [161]168Farmer6RIGHTepithelioidNOPAINFUL
1442015Akin [162]149NO48LEFTpapillaryNATESTICULAR MASS
1452015Bandyopadhyay [163]140FarmerNANApapillaryNASCROTAL SWELLING
1462015

Jankovichova

[164]

167Environmental residential roof eternit and occupational lorry driver construction material44LEFTepithelioid14 local recurrenceHYDROCELE
1472015Silverio [165]182NANANANANANA
1482015D’Antonio [166]180Occupational railway workers12RIGHT spermatic cord

tubulo-

papillarymm

NO 12PAINLESS MASS
1492015Segura [167] Gonzales158NO6LEFTepithelioidNO 6SWELLING
1502015Alesawi [168]169NO12RIGHT

tubulo-

papillary

NO 12HYDROCELE
1512016Hispan [169]193Occupational aluminum factory for 40 yearsNALEFT

tubulo-

papillary

NA cutaneous metastasisMUTIPLE NODULES
1522016

Mrinakova

[170]

267Occupational environmental62LEFT

tubulo-

papillary

24 recurrenceHYDROCELE
20environmental91LEFTepithelioidNO 91HYDROCELE
1532016Ahmed [171]145Occupaional truck driverNAspermatic cordbiphasicNASWELLING
1542016

Andresen

[172]

160Occupational27RIGHTNA24 recurrence

SWELLING

hydrocele

1552016Serio [173]277Occupational machines ship44 deadLEFTepithelioid26 recurrenceSWELLING
82NO63 deadLEFTepithelioid53 recurrencehydrocele
1562016

Bertolotto

[174]

764NANARIGHTepithelioidNASCROTAL ENLARGEMENT
60NA66LEFTepithelioidNO 66MASS
65NA132 deadLEFTepithelioidNASCROTAL ENLARGEMENT
70NA24 deadRIGHTepithelioidNASCROTAL ENLARGEMENT
82NA6RIGHTepithelioidNO 6PALPABLE MASS
63NANABILATERALNANASCROTAL ENLARGEMENT
75NANARIGHTNANAPALPABLE MASS
1572017Zhang [175]150NA24LEFTbiphasicNO 24PAINLESS ENLARGEMENT
1582017Arda [176]184NANALEFTepithelioidNOSCROTAL SWELLING
1592017

Recabal [177]

No individual data

1539-662/1542 medianNApapillaryNANA
1602017Shaikh [178]165NO24BILATERALbiphasicNO 24BILATERAL PAINLESS SCROTAL SWELLING
1612017An [179]774NONANAbiphasicNAHYDROCELE
67YES47NAbiphasicNO 47SCROTAL MASS
58NO65NAepithelioidNO 65SPERMATOCELE
43NO14NAepithelioid14 recurrenceSCROTAL MASS
47NO155NANANO 155HYDROCELE
85YES19NAepithelioidNO 19HYDROCELE
71NO15NANANO 15HYDROCELE
1622017

Maheshwari

[180]

120NO16 deadLEFTNANASCROTAL SWELLING
1632018Abello [181]180NO26RIGHTbiphasic24 recurrencePAINLESS TESTICULAR MASS
1642018Trenti [182]140NO72 NEDLEFT

tubulo-

papillary epithelioid

72 NEDHYDROCELE
1652018Zhang [183]165NO72 aliveLEFTNA72 metastasisHYDROCELE BILATERAL
2018 Current cases 475Occupational foundry worker for 4 years [46]141 aliveLEFT

tubulo-

papillary epithelioid

NoMASS HYDROCELE
77

Occupational asbestos cement worker for 23 years

asbestosis pleural plaques [45]

2 deadLEFT

tubulo-

papillary epithelioid

2 metastasisMASS
78Occupational ship machinist ship then reclaimed for 3 years [58]40 deadLEFT

tubulo-

papillary epithelioid

cardiopathMASS
63Occupational mason cutting plates eternit trucker for 14 years [41]3 aliveLEFT

tubulo-

papillary epithelioid

Recent case 3 months aliveMASS HYDROCELE

LEGEND: NA not available, NED no evidence of disease, DOD dead of disease, CT computer tomography, MUMP mesothelioma uncertain malignant potential

Summary features MMTVT cases (1943-2018) Biphasic papillary, pseudo-glandular component 8 Local recurrence metastasis 24 metastasis 42 alive local recurrence SWELLING HYDROCELE Huncharek [81] Wolanske [102] Iczkowski [107] Van Apeldoorn [117] SCROTAL ENLARGEMENT Chyluria Winstanley [119] SCROTAL SWELLING RECURRENT EPIDIDYMITIS Brimo MUMP [11] papillary tubulo papillary papillary tubulo papillary papillary tubulo papillary papillary tubulo papillary papillary tubulo papillary papillary tubulo papillary papillary tubulo papillary papillary tubulo papillary Aggarwal [133] tubulo- papillary Abdelrahman [142] RIGHT spermatic cord Busto Martin [152] tubulo papillary RIGHT Spermatic cord Jankovichova [164] tubulo- papillarymm tubulo- papillary tubulo- papillary Mrinakova [170] tubulo- papillary Andresen [172] SWELLING hydrocele Bertolotto [174] Recabal [177] No individual data Maheshwari [180] tubulo- papillary epithelioid tubulo- papillary epithelioid Occupational asbestos cement worker for 23 years asbestosis pleural plaques [45] tubulo- papillary epithelioid tubulo- papillary epithelioid tubulo- papillary epithelioid LEGEND: NA not available, NED no evidence of disease, DOD dead of disease, CT computer tomography, MUMP mesothelioma uncertain malignant potential Watenabe (1994)) [79] and Ascoli (1996) [89] reported two cases of multifocal mesothelioma; the subjects both had occupational exposure as insulators. Individual data were not available in three papers: Spiess (2005) [117], Gemba (2012) [152] and Recabal (2017) [178] which present case series. Our cases were retrieved from the Apulian malignant mesothelioma register Cor Apulia (Cor-operating centre regional), established in 1993 as a part of the ReNaM-Italian national mesothelioma register. The Apulia mesothelioma register collects data on all incident cases of mesothelioma (pleura, pericardium, peritoneum and tunica vaginalis testis) from 1993 to date. The regional register according to the national guidelines [185], using a standardized questionnaire and with direct interviews with patients or their relatives, obtained occupational and residential-environmental histories, lifestyle habits and the hobbies of the patients. Similarly, the best evidence of histological diagnosis, follow-up data and vital status of each patient were recorded.

Results

Since, in 1943, a confusing nomenclature arose, and in 1945 Golden and Ash [18] introduced the term “adenomatoid tumours”, De Klerk and Nime [186] reported in 1975 that, from 1912 to 1975, two hundred three cases of adenomatoid tumours (malignant adenomatoid tumours) of testicular and paratesticular tissues were reported in the English language literature. Therefore, Bisceglia (Bisceglia 2010) [135] reported fewer than 250 cases of testicular and paratesticular mesothelioma, Jankovichova reported approximately 250 cases, and Mrinakova reported approximately 300 cases [165, 171]. All of these cases comprised and could be categorized as MM, WDPM and MUMP or MLMP. In our review, we found 289 cases of MMTVT (Table 1). The last four cases reported in Table 1 were cases currently found in the Apulia regional registry of the mesothelioma, so the total number of cases reported is here 293. Among the 289 cases reported here from the literature, the main features are summarized in Table 2.
Table 2

289 MMTVT main features: age at diagnosis, side, histologic type, clinical presentation, duration of follow up, recurrence, asbestos exposure

Number of cases%
Age at diagnosis
 1-30279.3
 31-40248.3
 41-503211.07
 51-604314.8
 61-706422.1
 71-804816.6
 81-175.8
 NA(not available)3411.7
 Total289100
Laterality
 Right testis9231.8
 Left testis10435.9
 Bilateral62.07
 Others (spermatic cord, scrotum, epididymis, ecc.)72.4
 NA8027.6
 Total289100
Histologic type
 Epithelial15553.6
 Biphasic4515.5
 Sarcomatous51.7
 NA8429.06
 Total289100
Clinical presentation
 Mass5519.03
 Hydrocele8429.06
 Swelling7927.3
 Others (inguinal hernia, pain, hematoscrotum,ecc.)155.1
 NA5619.3
 Total289100
Duration of follow up in months
 2-126622.8
 13-368830.04
 37-60279.3
 61-96217.2
 97-13262.07
 133-56472.4
 NA7425.6
 Total289100
Recurrence
 Metastasis237.9
 Multifocal5318.3
 No11038.06
 NA10335.6
 Total289100
Asbestos exposure
 Yes8027.6
 No8830.4
 NA12141.8
 Total289100
289 MMTVT main features: age at diagnosis, side, histologic type, clinical presentation, duration of follow up, recurrence, asbestos exposure The characteristics of our cases are reported in Table 1 and summarized in Table 3; the age at diagnosis ranged from 63 to 78 years old, with an average age of 73.2 years old; the clinical onset was a mass, and only two cases also had hydroceles; all of the cases involved the left testicle. All of the patients underwent surgery (orchidectomy), and the histological types were epithelioid. IHC (immunohistochemistry) was always performed with calretinin, HBME1, CK AE1/AE3, EMA positive (Figs. 1, 2, and 3).
Table 3

Four MMTVT cases from the Apulia mesothelioma register

Case numberYear of diagnosisAge yearsClinical diagnosisHistological diagnosisIHCSurvival monthsExposure reliable professionalDuration of exposure Years- calendar yearsLatency years
1200675CATmm epithelioid with papillary tubule aspectsCalretinine+++, HBME1+++141foundry worker4 (1960-63)46
2200977CAT ecocolordopplermm epithelioid with papillary and microcystic aspectsCalretinine +++,CK AE1/AE3+++, vimentine+++, WT1 (80%) KI67(8%) nuclear grade 2, IM:3x10HPF2asbestos cement worker21 (1964-85)45
3200978CAT ecocolordopplermm epithelioid papillary tubule growth pattern solid and focally clear cell presence psammomatous bodiesCalretinine +++, CK AE1/AE3+++,EMA +++, HMBE1 +++, WT1+++ > 25% nuclear grade 2,3 IM:5x10HPF40naval machinist3 (1951-53)58
4201863CATmm epithelioid papillary (70%) and solid (30%) tubule growth patternCalretinine +++,CK AE1/AE3+++,HMBE1 +++, WT1(90%)KI67 10% papillary tubulum component and 40% solid component3bricklayer cutting plates eternit and trucker14 (1977-90)41
Fig. 1

Case number 4 Gross examination, lardaceous superficial thickening of the tunica albuginea

Fig. 2

Case number 4. Microscopic examination, pseudopapillary epithelioid neoplastic proliferation wrapping around the testicular parenchyma. Diffuse immunopositivity for calretinin antigen (× 200)

Fig. 3

Case number 4. Microscopic examination, pseudopapillary epithelioid neoplastic proliferation wrapping around the testicular parenchyma (H&E, X100)

Four MMTVT cases from the Apulia mesothelioma register Case number 4 Gross examination, lardaceous superficial thickening of the tunica albuginea Case number 4. Microscopic examination, pseudopapillary epithelioid neoplastic proliferation wrapping around the testicular parenchyma. Diffuse immunopositivity for calretinin antigen (× 200) Case number 4. Microscopic examination, pseudopapillary epithelioid neoplastic proliferation wrapping around the testicular parenchyma (H&E, X100) All of our cases were directly interviewed, and asbestos exposure was documented. Two patients had pleural plaques found on computerized axial tomography (CAT) examination. At the last date of follow-up, in September 2018, two patients were alive and two were dead: one died of disease metastasis, and the other died of cardiopathy. The median survival was 46.7 months (range 2-141), the latency period was a mean of 47.5 years (range 41-58), and the duration of asbestos exposure had a mean of 10.5 years (range 2-21).

Discussion

MMTVT is a rare neoplasm that constitutes 0.3-5% of all mesothelioma cases with a mortality rate of 53% at 2 years following diagnosis [176]. Pathogenesis predisposing factors are described as local trauma, herniorrhaphy, long-term hydrocele or spermatocele [129, 187–189], venereal diseases and ionizing radiation [96, 99]. The tunica vaginalis has a common embryological origin with the visceral pleura, peritoneum and pericardium [187]. Relative to histogenesis in the past, four embryologic hypotheses have been considered: endothelium, epithelial, mesonephric and mesothelial hypotheses [42]. Early writers believed that this tumour had a lymphangiomatous origin because the predominance of labyrinthine channels lined by seemingly flat endothelial cells embedded in a reticular stroma, subsequent microscopic investigations excluded the endothelial origin due to the presence of vacuolated cuboidal and columnar cells. [42]. The mesothelial character was supported by electron microscopic studies [190]. The tunica vaginalis develops from evagination of the peritoneum during fetal life, and it is an embryonic extension of the peritoneal mesothelium, resulting from the descent of the testis through the abdominal wall via the inguinal canal into the scrotum [68]. The epithelial lining of the urogenital tract has mesodermal (mesothelial) origin [191], and the mesothelium has the ability to differentiate into fibroblasts and mesonephric tubular structures, or rather, the mesothelial cells could have a multipotent evolution; they can differentiate in an epithelial or a fibroblastic direction [33, 192, 193]. The mesothelial hypothesis was also corroborated by the occurrence in a patient affected by Maffucci’s syndrome, a mesenchymal disease [50]. To date, there is agreement regarding some of the main features of this disease as shown below; moreover, it is difficult to diagnose preoperatively.

Symptomatology

MMTVT can be asymptomatic for a long time. Hydrocele, scrotal mass, a lack of pain, inguinal hernia, spermatocele, testicular torsion, previous herniorrhaphy, and post-traumatic injury are all possible clinical manifestations of the disease [147]. Long asymptomatic intervals from initial presentation to clinical recurrence have been reported [54], moreover, MMTVT might mimic epididymitis [147] .

Diagnosis

Computed tomography, ultrasound, ultrasonography (colour Doppler sonography), and cytological examination of the hydrocele fluid by sonographically guided fine-needle aspiration (FNA) [128, 137, 164] have been performed, although some authors [169, 173] do not agree with these methods due to the low sensitivity of cytology and the potential risk of metastasis, instead using gross pathology images and magnetic resonance imaging.

Macroscopic appearance gross findings

A firm painless scrotal mass [194], numerous small papillary lesions or multiple nodules studded on the internal surface of the hydrocele sac, diffuse thickening of the tunica vaginalis [195], and a solid coat around the tunica vaginalis with variable features.

Microscopic appearance findings

Malignant character is demonstrated by the growth pattern, cytological alterations, extensive tissue invasion, and metastases to the lymph nodes; early diagnosis is by cytologic examination of the hydrocele fluid. Nuclear atypia, mitotic activity, with a stroma invasion infiltrative pattern. Cellular nuclear pleomorphism and papillary configuration are signs of lethal potential [52]. An infiltrative pattern of growth with increased cellularity nuclear pleomorphism and high mitotic rate and stromal invasion [105, 195]. Large lymphoid cells with clear or slightly eosinophilic cytoplasm with large strongly atypical polymorphic nuclei and a great number of mitoses; epithelioid features with papillary growth, papillary tubules, and solid growth in invasive foci [196].

Histologically, it can be of three histologic types

Epithelial (papillary, tubuloalveolar-glandular or solid) [99], fibrosarcomatous or mesenchymal; biphasic; or mixed, associated with the papillary architecture with stromal invasion. Hallmarks of mesothelioma are epithelial cuboidal cells with microvilli, basement membranes, filaments and desmosomes [197].The criteria for malignancy are nuclear pleomorphism, mitotic activity and stromal invasion [13, 198, 199].

Histochemical-immunohistochemical features

IHC (immunohistochemistry) shows the presence of both cytokeratin and vimentin, suggesting the diagnosis of mesothelioma. Positive staining for cytokeratin, vimentin and Ema (epithelial membrane antigen), with negative staining for Cea carcinoembryonic antigen, Leu–M1, and cytokeratin 20 CKL20. Epithelial membrane antigen and factor VIII are strongly suggestive for the diagnosis of MM; mesothelioma-related markers include calretinin, thrombomodulin, CK5/6 (pleural), WT1 (Wilms tumour antibody), D2-40, CK7 (tunica vaginalis) [120, 162, 188, 198], CD20 +, and calretinin + [196, 200].

Electron microscopy

The microvilli are elongated and develop complex throughout the tumour; there are well-defined, mature desmosomes through the interdigitating portions of the cytoplasmatic membrane, and numerous cytoplasmatic filaments are observed [104, 151, 188]. In 2009, the International Mesothelioma Interest Group (IMIG) [201]) recommended IHC as the gold standard for the diagnosis of MM, instead of electron microscopy.

Ultrasonography [103]

The most common sonographic finding is the presence of heterogeneous nodular or papillary masses of the tunica vaginalis associated with a hydrocele or hypoechoic hydrocele with heterogeneous masses of increased echogenicity at the periphery [74, 115, 187, 202]. Lesions are closely related to the tunica vaginalis [196].

Laterality

Most cases are unilateral on presentation, while only a few cases of bilateral MMTVT have been reported [131]; in the present review, we found only six cases (2.03%) with reported bilateral disease [50, 93, 97, 111, 175, 179].The case reported by Slaysman (1982) [50] occurred in a young man of 20 years old affected by Maffucci syndrome. Distant spread usually occurs via lymphatics; the retroperitoneal nodes are the most common site of metastasis, while spinal metastasis was described by Mathew (1996) [90] and cutaneous metastasis has also been reported [34, 53, 61, 170]. The differential diagnosis includes mesothelial hyperplasia, adenomatoid tumour, benign papillary mesothelioma, borderline serous papillary tumours, serous carcinomas, carcinoma of the rete testis or epididymis and metastatic adenocarcinoma [26, 99, 188, 203]. Because of potential misdiagnosis, the best evidence for definitive diagnosis requires a panel of HIC markers [145, 198, 203]. The prognosis is poor. While MM of the pleura and peritoneum has an extremely poor prognosis, MMTVT has a better prognosis, but the natural history of this tumour suggests an aggressive behaviour, with a survival rate of less than 50% 2 years after diagnosis [176].Early diagnosis is of great importance for treatment and long-term survival, especially in young men [156, 160].

Treatment

A multidisciplinary approach of radical orchiectomy and retroperitoneal node dissection is the best choice for cases of this disease. Chemotherapy can be useful for regression of disseminated disease, although to date, because of the rarity of this disease, no statistically significant studies or large series are available to assess the role of adjuvant therapy (chemo- and radiotherapy) [204]. Long-term follow-up over 5 years is needed because late recurrence is not rare and, to date, an aggressive surgical approach is necessary to achieve a cure because of potential late recurrence or metastasis. Many authors have emphasized the importance of considering this tumour in men with scrotal masses and hydroceles [54], even in the absence of asbestos exposure [115, 122, 123]. Lifelong follow-up and management in a multidisciplinary setting are recommended [161, 168, 171]. Similarly, our review, which considered only malignant mesotheliomas in the English literature, as reported by the authors of the examined articles due to the temporal evolution of the histological classification of this pathology, as already noted, does not confirm the total number of cases as reported in previous reviews [149] including approximately 250 cases. Another limitation of this review is that no best evidence of diagnosis from early articles and no best evidence of asbestos exposure are available. The histologic prevalent pattern is epithelial (53.6%of all cases), followed by a mixed biphasic pattern in 15.5% and a fibrous sarcomatoid variant in 1.7%. The more frequent age at presentation ranges from 61 to 80 years old (38.7%). Hydrocele was present in 29.06% of the cases described and swelling in 27.3%. Two cases [79, 89] were not primary tumours but of multifocal origin, and the pleura and peritoneum were involved in two patients with heavy exposure to an insulator. Only 4.4% of cases had a follow-up of over 8 years. Sixty-six patients died of disease progression with an average survival of 24.2 months (range1-76); two cases with a long duration of follow-up died after 132 and 564 months; ultimately, the prognosis remains poor with only rare long-term survivors. The overall recurrence rate (recurrence or metastasis) was 26.2%, predominantly within the first 2 years of follow-up. Both cases reported by Mathew (1996) [90] presented spinal metastasis, and the case reported by Hispan (2016) [170] presented cutaneous metastasis. Finally, in the papers by Spiess (2005) [117], Gemba (2012) [152] and Recabal (2017) [178], no individual data were reported. In previous reviews, a statistically significant correlation was reported between survival with age < 60 years old and organ-confined disease at diagnosis [74, 202]. Assessment of prognostic parameters revealed a significant correlation of the patient’s age with survival [96]. Radical inguinal orchiectomy might contribute to a better prognosis [112]. Due to the possibility of late tumour recurrence reported in 2.7% [96], lifelong follow-up can be recommended and should be offered to the patient because of the metastatic potential of the tumour; in fact, recurrence can occur as late as 15 years postoperatively [123, 205]. Regarding risk factors, the only causal factor so far ascertained is asbestos exposure, and exposure to different asbestos-containing materials is the only well-documented risk factor [87, 96], as stated by IARC (international agency on cancer research) (2012) [1], although information about exposure might not always have been adequate. Nevertheless, there are authors who do not agree with the absence, until today, of analytical case-control epidemiologic studies to test this relationship [189]. Asbestos is an ascertained carcinogen [1] in the development of mesotheliomas. It is necessary to bear in mind that it is ubiquitous not only in the workplace but also in the general environment [206]. The first study reporting an MMTVT case, diagnosed in 1969, with asbestos exposure was published in 1976 by Fligiei and Kaneko [38] in a pipe insulator exposed for 40 years. In the same year, Pizzolato and Lamberty [40] reported a case in a sugar refinery worker. Since the first case of MMTVT described in 1976 by Fligiel and Kaneko (Fligiel 1976 [38], it has been supposed that the asbestos fibres from the lung can reach the tunica vaginalis by a lymphatic or bloodstream route [207, 208]. Mirabella (1991) [209], in his review of the literature, reported eleven cases with occupational asbestos exposure. In the review by Jones (1995) [87] of a total of 63 cases, 48% had histories of asbestos exposure, while in Mensi’s report (2012) [149], 61% of cases had asbestos exposure. Overall, asbestos exposure was investigated only in 58% of all cases reported in this review, while in 41.8%, these data were not available. Notably, in many reports, there was no anamnestic reconstruction of any asbestos exposure. A history of direct occupational, environmental or family asbestos exposure is found in 27.6% of these cases. Among these cases (80 cases) 12.5% reported generic occupational exposure the others 87.5% have a documented history of asbestos exposure. Among the latter there are insulators, dock workers, steel industry workers, farmers, shipyard workers and other different occupations in sectors known to involve asbestos exposure. To be noted there are four cases with environmental exposure, six with household, family or hobby exposure and five cases with or without declared exposure but with pleural plaques or asbestos bodies. The duration of asbestos exposure is recorded in 108 articles of the 165 reviewed (65.45%). In these articles 50 ascertained the exposure (30.30%) while in 58 articles it was excluded (35.15%). The duration of exposure is between 4 and 50 years, for occupational exposures only the range is 4-40 years. For the new employment cases presented here the range is 3-23 years. The true incidence of asbestos exposure in these reported MMTVT cases is underestimated because of insufficient information, especially for the earlier cases and case series described until the beginning of the 2000s, when the scientific community became aware of the risk factors for this disease represented by asbestos exposure [158]. Similarly, because of the long latency period, even over decades, poor patient recall in the reconstruction of asbestos exposure and occupational histories or the patient being unaware of using materials containing asbestos [171], until now, the quality of these data was quite unclear, which might have caused the majority of MMTVT cases to date appearing to be idiopathic, and there is no accurate assessment of asbestos exposure association. However, latency in Antman’s (1984)) [54] case series ranged from 16 to 40 years. The higher incidence of MMTVT among older patients is related to longer exposure to asbestos with a latency range of 10-40 years. A positive history of asbestos exposure or asbestos-containing materials constitutes a risk for the development of an MMTVT and should be monitored [123]. The Apulia mesothelioma registry recorded 4 cases of MMTVT from 1993 to 2018, accounting for 0.3% of all MM cases reported in the regional register during this period. This percentage is consistent with the national Renam data (0.28%) from the national Italian mesothelioma registry [2]. The age at diagnosis was an average of 73 years old, and the mean survival (46 months) was consistent with that reported in the literature [188]. The family histories and clinical-medical histories of the patients were unremarkable. None of our patients underwent chemotherapy or radiotherapy cycles after orchidectomy. The Renam data [2] showed that more than 59% of MMTVT cases had asbestos exposure. Our four cases, all with occupational exposure, had a latency of 47 years and an exposure length of 10.5 years, and these data are concordant with the descriptions in the literature of the aetiological role of asbestos in the pathogenesis of MM [3, 13, 206]. The accurate diagnosis of primary malignant MMTVT and occupational anamnesis are helpful for medicolegal compensation considerations, especially for the cases associated with asbestos exposure [13]. The case described here was referred to the Italian workers’ compensation authority (Inail - National Insurance Institution for Occupational Accidents). Recently, many studies have demonstrated molecular changes in MM with multiple chromosomal alterations [184, 210–214]. Chromosomal abnormalities in cases of MMTVT were described for the first time by Serio (Serio 2016) [174]in two cases with comparative genomic hybridization (CGH) findings. The two cases showed several gains and losses, in particular, identical lost regions at 1p13.3 → q21.1; 19q13.42; 21q22.2; and 22q12.2 (tumour suppressor gene NF2). Jean (Jean 2012) [215] hypothesized that NF2 regulates cell growth function, and its inactivation could be related to tumour progression and patient survival. We are deepening the study of these new cases, all with ascertained exposure to asbestos, to understand whether there are specific DNA copy number changes in MMTVT and investigating the relative genes involved to define whether they are or are not the same as those reported in pleural MM, particularly in relation to asbestos exposure, and whether they might be useful in elucidating tumorigenesis and predicting prognosis.

Conclusions

Although this systematic review shows that only 27.6% of the cases reported in this long period of time (1943-2018) had asbestos exposure must be underlined that in 41.8% of the cases in the literature exposure to asbestos is not investigated. In our opinion, to establish a broad consensus on the causal relationship between asbestos and MMTVT in the scientific community, we will need to analyze these relationships with analytical epidemiological studies. A case control study on the data from the national mesothelioma registry is under way in Italy, together with molecular epidemiological studies.
  197 in total

1.  Case report: ultrasound appearances of a malignant mesothelioma of the tunica vaginalis testis.

Authors:  J M Fields; S A Russell; S M Andrew
Journal:  Clin Radiol       Date:  1992-08       Impact factor: 2.350

2.  Mesothelioma of the tunica vaginalis of the testis.

Authors:  J G Noble; A Watkins; M E Chappell; A D Heath
Journal:  Br J Urol       Date:  1992-09

3.  Malignant mesothelioma of the tunica vaginalis testis: a case illustrating Doppler color flow imaging and its potential for preoperative diagnosis.

Authors:  James Boyum; Neil F Wasserman
Journal:  J Ultrasound Med       Date:  2008-08       Impact factor: 2.153

Review 4.  Pathology of malignant mesothelioma.

Authors:  R L Attanoos; A R Gibbs
Journal:  Histopathology       Date:  1997-05       Impact factor: 5.087

5.  Extremely rare tumour--malignant mesothelioma of tunica vaginalis testis.

Authors:  T Jankovichova; M Jankovich; D Ondrus; K Kajo; J Dubravicky; J Breza
Journal:  Bratisl Lek Listy       Date:  2015       Impact factor: 1.278

6.  Fourteen-year experience with the intraoperative frozen section examination of testicular lesion in a tertiary university center.

Authors:  Patricia Caseiro Silverio; Fabian Schoofs; Christophe E Iselin; Jean-Christophe Tille
Journal:  Ann Diagn Pathol       Date:  2015-02-24       Impact factor: 2.090

7.  Purpuric nodules along a surgical scar. Metastatic malignant mesothelioma of the tunica vaginalis testis.

Authors:  A K Joseph; J A Tschen; S A Sekula; S H Sudduth
Journal:  Arch Dermatol       Date:  1995-04

Review 8.  Malignant mesothelioma of the tunica vaginalis testis. Report of a case and review of the literature.

Authors:  H Kuwabara; H Uda; H Sakamoto; A Sato
Journal:  Acta Pathol Jpn       Date:  1991-11

9.  Malignant mesothelioma of the testicular tunica vaginalis.

Authors:  G Serio; M Ceppi; A Fonte; M Martinazzi
Journal:  Eur Urol       Date:  1992       Impact factor: 20.096

10.  Fibrous mesotheliomas (pseudofibroma) of the scrotal sac: a light and ultrastructural study.

Authors:  B Benisch; B Peison; H J Sobel; E Marquet
Journal:  Cancer       Date:  1981-02-15       Impact factor: 6.860

View more
  7 in total

1.  Response to the "Letter to the Editor" by Gabor Mezei et al., Comments on Vimercati et al., 2019, "Asbestos exposure and malignant mesothelioma of the tunica vaginalis testis: a systematic review and the experience of the Apulia (Southern Italy) mesothelioma register".

Authors:  Luigi Vimercati; Domenica Cavone; Maria Celeste Delfino; Luigi De Maria; Antonio Caputi; Giovanni Maria Ferri; Gabriella Serio
Journal:  Environ Health       Date:  2019-12-26       Impact factor: 5.984

2.  Comments on Vimercati et al., 2019, "Asbestos exposure and malignant mesothelioma of the tunica vaginalis testis: a systematic review and the experience of the Apulia (southern Italy) mesothelioma register".

Authors:  Gabor Mezei; Ellen T Chang; Fionna S Mowat; Suresh H Moolgavkar
Journal:  Environ Health       Date:  2019-12-26       Impact factor: 5.984

3.  Association between asbestos exposure and pericardial and tunica vaginalis testis malignant mesothelioma: a case-control study and epidemiological remarks.

Authors:  Alessandro Marinaccio; Dario Consonni; Carolina Mensi; Dario Mirabelli; Enrica Migliore; Corrado Magnani; Davide Di Marzio; Valerio Gennaro; Guido Mazzoleni; Paolo Girardi; Corrado Negro; Antonio Romanelli; Elisabetta Chellini; Iolanda Grappasonni; Gabriella Madeo; Elisa Romeo; Valeria Ascoli; Francesco Carrozza; Italo Francesco Angelillo; Domenica Cavone; Rosario Tumino; Massimo Melis; Stefania Curti; Giovanni Brandi; Stefano Mattioli; Sergio Iavicoli
Journal:  Scand J Work Environ Health       Date:  2020-04-07       Impact factor: 5.024

4.  Mesothelioma and Colorectal Cancer: Report of Four Cases with Synchronous and Metachronous Presentation.

Authors:  Gabriella Serio; Federica Pezzuto; Francesco Fortarezza; Andrea Marzullo; Maria Celeste Delfino; Antonio d'Amati; Daniele Egidio Romano; Sonia Maniglio; Concetta Caporusso; Teresa Lettini; Domenica Cavone; Luigi Vimercati
Journal:  Int J Mol Sci       Date:  2022-02-27       Impact factor: 5.923

Review 5.  Microbiomes, Epigenomics, Immune Response, and Splicing Signatures Interplay: Potential Use of Combination of Regulatory Pathways as Targets for Malignant Mesothelioma.

Authors:  Botle Precious Setlai; Zilungile Lynette Mkhize-Kwitshana; Ravi Mehrotra; Thanyani Victor Mulaudzi; Zodwa Dlamini
Journal:  Int J Mol Sci       Date:  2022-08-12       Impact factor: 6.208

6.  Primary Ovarian Mesothelioma: A Case Series with Electron Microscopy Examination and Review of the Literature.

Authors:  Luigi Vimercati; Domenica Cavone; Maria Celeste Delfino; Biagio Bruni; Luigi De Maria; Antonio Caputi; Stefania Sponselli; Roberta Rossi; Leonardo Resta; Francesco Fortarezza; Federica Pezzuto; Gabriella Serio
Journal:  Cancers (Basel)       Date:  2021-05-10       Impact factor: 6.639

Review 7.  Extracellular Vesicles-Based Drug Delivery Systems: A New Challenge and the Exemplum of Malignant Pleural Mesothelioma.

Authors:  Stefano Burgio; Leila Noori; Antonella Marino Gammazza; Claudia Campanella; Mariantonia Logozzi; Stefano Fais; Fabio Bucchieri; Francesco Cappello; Celeste Caruso Bavisotto
Journal:  Int J Mol Sci       Date:  2020-07-30       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.